What's new

Orphan designation: Nipocalimab Prevention of fetal and neonatal alloimmune thrombocytopenia Positive

Orphan designation: Nipocalimab Prevention of fetal and neonatal alloimmune thrombocytopenia Positive

Jun 10, 2025 - 08:25
 0
Orphan designation: Nipocalimab Prevention of fetal and neonatal alloimmune thrombocytopenia Positive
Orphan designation: Nipocalimab Prevention of fetal and neonatal alloimmune thrombocytopenia Positive
Read More

Tags:

Previous Article

Orphan designation: Adeno-associated viral vector serotype 3B encoding human mul...

Next Article

Get Ready for the New Rules of War in the Indo-Pacific

Related Posts

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Annex to 27-30 January 2025 CHMP Minutes

May 28, 2025  0